Delayed till Feb 29th. Quick reading says its better overall based on pricing, costs and Reserves. Will need to review it after the 10-Q which is also out. Doubt that OAS sells to another party. Still hangs on MOB.
Webinar: What investors should know about what it takes for ASX-listed companies to get medical developments to market